Chen J, Baxi K, Lipsitt A, Hensch N, Wang L, Sreenivas P, et al. Defining function of wild-type and three patient-specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma. elife. 2023;12: pubmed publisher

Rojas E, Corchete L, de Ramón C, Krzeminski P, Quwaider D, Garcia Sanz R, et al. Expression of p53 protein isoforms predicts survival in patients with multiple myeloma. Am J Hematol. 2022;97:700-710 pubmed publisher

Cheng F, Dou J, Zhang Y, Wang X, Wei H, Zhang Z, et al. Urolithin A Inhibits Epithelial-Mesenchymal Transition in Lung Cancer Cells via P53-Mdm2-Snail Pathway. Onco Targets Ther. 2021;14:3199-3208 pubmed publisher

Scarpa M, Marchiori C, Scarpa M, Castagliuolo I. CD80 expression is upregulated by TP53 activation in human cancer epithelial cells. Oncoimmunology. 2021;10:1907912 pubmed publisher

Feng Y, Liu S, Zha R, Sun X, Li K, ROBLING A, et al. Mechanical Loading-Driven Tumor Suppression Is Mediated by Lrp5-Dependent and Independent Mechanisms. Cancers (Basel). 2021;13: pubmed publisher

Mitra S, Veppil Muralidharan S, Di Marco M, Juvvuna P, Thankaswamy Kosalai S, Reischl S, et al. Subcellular distribution of p53 by the p53-responsive lncRNA NBAT1 determines chemotherapeutic response in neuroblastoma. Cancer Res. 2020;: pubmed publisher

Ristic B, Sivaprakasam S, Narayanan M, Ganapathy V. Hereditary hemochromatosis disrupts uric acid homeostasis and causes hyperuricemia via altered expression/activity of xanthine oxidase and ABCG2. Biochem J. 2020;477:1499-1513 pubmed publisher

Abdel Rashid R, Omar S, Teiama M, Khairy A, Magdy M, Anis B. Fabrication Of Gold Nanoparticles In Absence Of Surfactant As In Vitro Carrier Of Plasmid DNA. Int J Nanomedicine. 2019;14:8399-8408 pubmed publisher

Matreyek K, Stephany J, Chiasson M, Hasle N, Fowler D. An improved platform for functional assessment of large protein libraries in mammalian cells. Nucleic Acids Res. 2019;: pubmed publisher

Hennigan R, Fletcher J, Guard S, Ratner N. Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. Sci Signal. 2019;12: pubmed publisher

Ishak Gabra M, Yang Y, Lowman X, Reid M, Tran T, Kong M. IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivation. Oncogenesis. 2018;7:93 pubmed publisher

Yang L, Zhou J, Meng F, Fu C, Zou X, Liu J, et al. G1 phase cell cycle arrest in NSCLC in response to LZ-106, an analog of enoxacin, is orchestrated through ROS overproduction in a P53-dependent manner. Carcinogenesis. 2019;40:131-144 pubmed publisher

Dunphy G, Flannery S, Almine J, Connolly D, Paulus C, Jønsson K, et al. Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage. Mol Cell. 2018;71:745-760.e5 pubmed publisher

Frost J, Mendez M, Soriano A, Crisostomo L, Olanubi O, Radko S, et al. Adenovirus 5 E1A-Mediated Suppression of p53 via FUBP1. J Virol. 2018;92: pubmed publisher

Tan Z, Li J, Zhang X, Yang X, Zhang Z, Yin K, et al. P53 Promotes Retinoid Acid-induced Smooth Muscle Cell Differentiation by Targeting Myocardin. Stem Cells Dev. 2018;27:534-544 pubmed publisher

Luo J, Zhang M, Huang H, Wang Y, Yuan X, Ma S, et al. Matrilin-2 regulates proliferation, apoptosis and cell cycle during radiation-induced injury in HPAEpiC cell. Biochem Biophys Res Commun. 2017;485:577-583 pubmed publisher

Loughery J, Cox M, Smith L, Meek D. Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters. Nucleic Acids Res. 2014;42:7666-80 pubmed publisher